Abstract

N-methyl-D-aspartate receptor (NMDAr) antagonists such as ketamine (KET) produce psychotic-like behavior in both humans and animal models. NMDAr hypofunction affects normal oscillatory dynamics and synaptic plasticity in key brain regions related to schizophrenia, particularly in the hippocampus and the prefrontal cortex. It has been shown that prior long-term potentiation (LTP) occluded the increase of synaptic efficacy in the hippocampus-prefrontal cortex pathway induced by MK-801, a non-competitive NMDAr antagonist. However, it is not clear whether LTP could also modulate aberrant oscillations and short-term plasticity disruptions induced by NMDAr antagonists. Thus, we tested whether LTP could mitigate the electrophysiological changes promoted by KET. We recorded HPC-PFC local field potentials and evoked responses in urethane anesthetized rats, before and after KET administration, preceded or not by LTP induction. Our results show that KET promotes an aberrant delta-high-gamma cross-frequency coupling in the PFC and an enhancement in HPC-PFC evoked responses. LTP induction prior to KET attenuates changes in synaptic efficiency and prevents the increase in cortical gamma amplitude comodulation. These findings are consistent with evidence that increased efficiency of glutamatergic receptors attenuates cognitive impairment in animal models of psychosis. Therefore, high-frequency stimulation in HPC may be a useful tool to better understand how to prevent NMDAr hypofunction effects on synaptic plasticity and oscillatory coordination in cortico-limbic circuits.

Highlights

  • N-methyl-D-aspartate receptor (NMDAr) antagonists such as ketamine (KET) produce psychotic-like behavior in both humans and animal models

  • Consistent with previous reports[37,38], we show that in DEA there is a predominance of delta oscillations (1 Hz), while in ACT epochs there is a significant decrease in delta (PFC: t(7)=9.712, p < 0.0001; HPC: Wilcoxon matched-pairs signed-rank test, n = 8, p = 0.0078), and an increase in theta (PFC: t(7) = 13.15, p < 0.0001; HPC: t(7) = 4.474, p = 0.0029), low-gamma (PFC: t(7) = 4.054, p = 0.0048; HPC: t(7) = 2.357, p = 0.0506) and high-gamma (PFC: t(7) = 4.964, p = 0.0016; HPC: Wilcoxon matched-pairs signed-rank test, n = 8, p = 0.1094) relative power for both PFC and HPC

  • We show that NMDAr blockade leads to an increase in evoked field post-synaptic potential amplitude (F(20,260) = 1.611 significant interaction between groups p = 0.050; Bonferroni post-hoc test are bottom of the graphs) and a robust reduction of paired-pulse facilitation (PPF) (F(20,260) = 8.205 significant interaction between groups p =

Read more

Summary

Introduction

N-methyl-D-aspartate receptor (NMDAr) antagonists such as ketamine (KET) produce psychotic-like behavior in both humans and animal models. Kiss et al (2011) demonstrated that acute MK-801 produced a new brain state of persistent slow oscillations (0.5–1.5 Hz) associated with short-term synaptic plasticity impairment at subiculum-mPFC pathway in urethane-anesthetized rats These MK-801 induced effects were reversed by treatment with the AMPA receptor potentiator (LY451395), reinforcing the idea that AMPAr transmission enhancement could be an interesting target to attenuate alterations produced by NMDAr hypofunction[35]. We tested whether prior LTP was able to occlude the ketamine effects on synaptic plasticity and oscillatory patterns in the HPC-PFC pathway To test this hypothesis, we first characterized sleep-like brain state oscillations under urethane[35] and compared PFC field responses induced by HPC stimulation and HPC-PFC oscillatory coupling before and after ketamine treatment. Our data suggest that modulation of synaptic plasticity in HPC-PFC circuits might be a useful tool to better understand how to prevent dysfunctions induced by NMDAr blockade

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call